— Know what they know.
Not Investment Advice
Also trades as: PCLO.V (TSXV) · $vol 0M

PCLOF Earnings

PharmaCielo Ltd.
1W: -6.9% 1M: -23.6% 3M: -29.5% YTD: -44.6% 1Y: +51.1% 3Y: -75.4% 5Y: -96.4%
$0.04
-0.00 (-2.78%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · $6.6M mcap · 180M float · 0.032% daily turnover · Short 35% of daily vol
Last Earnings 2026-07-30
EPS
C$-0.00 (US$-0.00)
▲ Beat +79.6%
Revenue
C$979K ($687K)
▼ Miss -81.1%
EPS Beat Streak: 2 quarters
Next Earnings 2026-11-26
EPS Estimate
C$-0.03 (US$-0.02)
Range: C$-0.03 - C$-0.03
Revenue Estimate
C$771K ($541K)
1 analysts
1 USD = 1.43 CAD

Estimate vs Actual

Earnings Surprise History

4/17
EPS Beats
0/17
Revenue Beats
24%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2030-12-31 C$-0.05 C$-0.05 — C$24,554,770 C$24,548,403
2026-10-02 annual 2028-12-31 C$-0.19 C$-0.19 — C$4,259,481 C$4,258,376
2026-10-02 quarter 2028-03-30 C$-0.01 C$-0.01 — C$7,028,261 C$7,026,438
2026-10-02 quarter 2026-12-30 C$-0.03 C$-0.03 — C$771,116 C$770,916
2026-10-02 quarter 2026-09-30 C$-0.03 C$-0.03 — C$7,342,977 C$7,341,073
2026-10-02 quarter 2029-09-30 C$0.04 C$0.04 — C$19,049,092 C$19,044,152
2026-10-02 quarter 2027-03-30 C$-0.03 C$-0.03 — C$586,873 C$586,720
2026-10-02 annual 2029-12-31 C$-0.15 C$-0.15 — C$3,173,596 C$3,172,773
2026-10-02 quarter 2028-09-30 C$0.02 C$0.02 — C$12,297,798 C$12,294,609
2026-10-02 quarter 2027-12-30 C$-0.02 C$-0.02 — C$5,423,917 C$5,422,510
2026-10-02 annual 2026-12-31 C$-0.41 C$-0.41 — C$3,278,017 C$3,278,017
2026-10-02 annual 2027-12-31 C$-0.29 C$-0.29 — C$1,031,395 C$1,031,128
2026-10-02 quarter 2029-03-30 C$0.03 C$0.03 — C$16,413,138 C$16,408,881
2026-10-02 quarter 2028-12-30 C$0.03 C$0.03 — C$14,772,667 C$14,768,836
2026-10-02 quarter 2029-06-30 C$0.04 C$0.04 — C$19,049,092 C$19,044,152
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms